UNC Study Reveals Promising New Therapy for Non-Hodgkin Lymphoma
The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma
UNC Researchers Create More Effective, Less Toxic Immunotherapy to Combat Blood Cancer
The newly developed cells address a significant limitation present in existing treatment approaches and may offer a promising solution for acute myeloid leukemia.
Cancer, Immunology And Microbiology, News, Oncology, Research, Vital Signs
Traveling with Hope: Rex Mobile Mammography Celebrates 25 Years of Service
Celebrating its 25th anniversary, the Rex Mobile Mammography, a department of UNC Health Rex Hospital, will welcome a new mobile mammography unit this year named Hope Esperanza, or “Hope.”
A New Clinical Trial for Metastatic Breast Cancer Opens
A new clinical trial that adjusts treatment as breast cancer evolves is now open and enrolling patients at UNC Lineberger Comprehensive Cancer Center.
Cancer, Clinical Research, News, Obstetrics and Gynecology, Research, UNC Health, Vital Signs, Women's Health
Two UNC School of Medicine Researchers Receive $1 Million Grants to Advance Innovative Cancer Research
The investment will help researchers develop innovative research projects aimed at improving the treatment of solid tumors, cervical cancer, lung cancer, and more.
Cancer, Immunology And Microbiology, News, Obstetrics and Gynecology, Research, Vital Signs
Cook Elected to 2025 AAAS Class of Honorary Fellows
The prestigious honor recognizes biochemist Jean Cook, PhD, and her work on cancer development and the human cell cycle, a biological process crucial for development, healing, and continued maintenance of…
Milner Awarded $1 Million for Pancreatic Cancer Research
The All-Star Translational Award from the V Foundation will help create new treatments to help patients better fight off pancreatic cancer, one of the most lethal types of cancer.
UNC Research Shows Natural Compound Could Benefit Lymphoma Patients
New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.
Cancer, Immunology And Microbiology, MICROIMM Featured, News, Research
UNC researchers develop single sample classifier to predict cancer-associated fibroblast subtypes in patient samples
Published in Cell Reports Medicine, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy response.
“Data for Everyone”: A New Cancer Dashboard Launches at UNC Lineberger Comprehensive Cancer Center
The tool is a one-stop resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs…
Cancer, News, North Carolina, Oncology, Research, Vital Signs
